|
1
|
Wang J, Duan Y, Sluijter JP and Xiao J:
Lymphocytic subsets play distinct roles in heart diseases.
Theranostics. 9:4030–4046. 2019.
|
|
2
|
Brownrigg JR, Leo V, Rose J, Low E,
Richards S, Carr-White G and Elliott PM: Epidemiology of
cardiomyopathies and incident heart failure in a population-based
cohort study. Heart. 108:1383–1391. 2022.
|
|
3
|
Wang W, Liu Y, Liu J, Yin P, Wang L, Qi J,
You J, Lin L, Meng S, Wang F and Zhou M: Mortality and years of
life lost of cardiovascular diseases in China, 2005-2020: Empirical
evidence from national mortality surveillance system. Int J
Cardiol. 340:105–112. 2021.
|
|
4
|
Harris NR, Bálint L, Dy DM, Nielsen NR,
Méndez HG, Aghajanian A and Caron KM: The ebb and flow of cardiac
lymphatics: A tidal wave of new discoveries. Physiol Rev.
103:391–432. 2023.
|
|
5
|
Monaghan RM, Page DJ, Ostergaard P and
Keavney BD: The physiological and pathological functions of VEGFR3
in cardiac and lymphatic development and related diseases.
Cardiovasc Res. 117:1877–1890. 2021.
|
|
6
|
Vuorio T, Ylä-Herttuala E, Laakkonen JP,
Laidinen S, Liimatainen T and Ylä-Herttuala S: Downregulation of
VEGFR3 signaling alters cardiac lymphatic vessel organization and
leads to a higher mortality after acute myocardial infarction. Sci
Rep. 8:167092018.
|
|
7
|
Aspelund A, Robciuc MR, Karaman S, Makinen
T and Alitalo K: Lymphatic system in cardiovascular medicine. Circ
Res. 118:515–530. 2016.
|
|
8
|
Nair AS: Scientometrics in medical
journals: Indices, their pros and cons. Indian J Anaesth.
63:955–957. 2019.
|
|
9
|
Martinez P, Al-Hussein M and Ahmad R: A
scientometric analysis and critical review of computer vision
applications for construction. Autom Constr. 107:1029472019.
|
|
10
|
Chen C: CiteSpace: A practical guide for
mapping scientific literature. New York: Nova Science Publishers;
2016
|
|
11
|
Bilal, Hysa E, Akbar A, Yasmin F, Rahman
AU and Li S: Virtual learning during the covid-19 pandemic: A
bibliometric review and future research agenda. Risk Manag Healthc
Policy. 15:1353–1368. 2022.
|
|
12
|
Force MM and Robinson NJ: Encouraging data
citation and discovery with the data citation index. J Comput Aided
Mol Des. 28:1043–1048. 2014.
|
|
13
|
Dori Y, Keller MS, Rome JJ, Gillespie MJ,
Glatz AC, Dodds K, Goldberg DJ, Goldfarb S, Rychik J and Itkin M:
Percutaneous lymphatic embolization of abnormal pulmonary lymphatic
flow as treatment of plastic bronchitis in patients with congenital
heart disease. Circulation. 133:1160–1670. 2016.
|
|
14
|
Henri O, Pouehe C, Houssari M, Galas L,
Nicol L, Edwards-Lévy F, Henry JP, Dumesnil A, Boukhalfa I, Banquet
S, et al: Selective stimulation of cardiac lymphangiogenesis
reduces myocardial edema and fibrosis leading to improved cardiac
function following myocardial infarction. Circulation.
133:1484–1497. 2016.
|
|
15
|
Fudim M, Salah HM, Sathananthan J, Bernier
M, Pabon-Ramos W, Schwartz RS, Rodés-Cabau J, Côté F, Khalifa A,
Virani SA and Patel MR: Lymphatic dysregulation in patients with
heart failure: JACC review topic of the week. J Am Coll Cardiol.
78:66–76. 2021.
|
|
16
|
Liu MM, Peng J, Guo YL, Zhu CG, Wu NQ, Xu
RX, Dong Q, Cui CJ and Li JJ: SORBS2 as a molecular target for
atherosclerosis in patients with familial hypercholesterolemia. J
Transl Med. 20:2332022.
|
|
17
|
Oliver G, Kipnis J, Randolph GJ and Harvey
NL: The lymphatic vasculature in the 21st century: Novel functional
roles in homeostasis and disease. Cell. 182:270–296. 2020.
|
|
18
|
Rademakers T, van der Vorst EP,
Daissormont IT, Otten JJ, Theodorou K, Theelen TL, Gijbels M,
Anisimov A, Nurmi H, Lindeman JH, et al: Adventitial lymphatic
capillary expansion impacts on plaque T cell accumulation in
atherosclerosis. Sci Rep. 7:452632017.
|
|
19
|
Nielsen NR, Rangarajan KV, Mao L, Rockman
HA and Caron KM: A murine model of increased coronary sinus
pressure induces myocardial edema with cardiac lymphatic dilation
and fibrosis. Am J Physiol Heart Circ Physiol. 318:H895–H907.
2020.
|
|
20
|
Chakraborty A, Scogin CK, Rizwan K, Morley
TS and Rutkowski JM: Characterizing lymphangiogenesis and
concurrent inflammation in adipose tissue in response to VEGF-D.
Front Physiol. 11:3632020.
|
|
21
|
Wada H, Suzuki M, Matsuda M, Ajiro Y,
Shinozaki T, Sakagami S, Yonezawa K, Shimizu M, Funada J, Takenaka
T, et al: VEGF-C and mortality in patients with suspected or known
coronary artery disease. J Am Heart Assoc. 7:e103552018.
|
|
22
|
Milasan A, Smaani A and Martel C: Early
rescue of lymphatic function limits atherosclerosis progression in
Ldlr−/− mice. Atherosclerosis. 283:106–119. 2019.
|
|
23
|
Drosos I, Pavlaki M, Ortega Carrillo MDP,
Kourkouli A, Buschmann K, Konstantinou F, Gogiraju R, Bochenek ML,
Chalikias G, Tortopidis C, et al: Increased lymphangiogenesis and
lymphangiogenic growth factor expression in perivascular adipose
tissue of patients with coronary artery disease. J Clin Med.
8:10002019.
|
|
24
|
Singla B, Lin HP, Chen A, Ahn W, Ghoshal
P, Cherian-Shaw M, White J, Stansfield BK and Csányi G: Role of
R-spondin 2 in arterial lymphangiogenesis and atherosclerosis.
Cardiovasc Res. 117:1489–1509. 2021.
|
|
25
|
Okura T, Ohkawara B, Takegami Y, Ito M,
Masuda A, Seki T, Ishiguro N and Ohno K: Mianserin suppresses
R-spondin 2-induced activation of Wnt/β-catenin signaling in
chondrocytes and prevents cartilage degradation in a rat model of
osteoarthritis. Sci Rep. 9:28082019.
|
|
26
|
Wu C, Qiu S, Lu L, Zou J, Li WF, Wang O,
Zhao H, Wang H, Tang J, Chen L, et al: RSPO2-LGR5 signaling has
tumour-suppressive activity in colorectal cancer. Nat Commun.
5:31492014.
|
|
27
|
Yu SJ, Wu KJ, Wang YS, Song JS, Wu CH, Jan
JJ, Bae E, Chen H, Shia KS and Wang Y: Protective effect of CXCR4
antagonist CX807 in a rat model of hemorrhagic stroke. Int J Mol
Sci. 21:70852020.
|
|
28
|
Reinhardt SW, Lin CJ, Novak E and Brown
DL: Noninvasive cardiac testing vs clinical evaluation alone in
acute chest pain: A secondary analysis of the ROMICAT-II randomized
clinical trial. JAMA Intern Med. 178:212–219. 2018.
|
|
29
|
Ibanez B, Aletras AH, Arai AE, Arheden H,
Bax J, Berry C, Bucciarelli-Ducci C, Croisille P, Dall'Armellina E,
Dharmakumar R, et al: Cardiac MRI endpoints in myocardial
infarction experimental and clinical trials: JACC scientific expert
panel. J Am Coll Cardiol. 74:238–256. 2019.
|
|
30
|
Klaourakis K, Vieira JM and Riley PR: The
evolving cardiac lymphatic vasculature in development, repair and
regeneration. Nat Rev Cardiol. 18:368–379. 2021.
|
|
31
|
Liu X, De la Cruz E, Gu X, Balint L,
Oxendine-Burns M, Terrones T, Ma W, Kuo HH, Lantz C, Bansal T, et
al: Lymphoangiocrine signals promote cardiac growth and repair.
Nature. 588:705–711. 2020.
|
|
32
|
Lohela M, Bry M, Tammela T and Alitalo K:
VEGFs and receptors involved in angiogenesis versus
lymphangiogenesis. Curr Opin Cell Biol. 21:154–165. 2009.
|
|
33
|
Hendel RC, Henry TD, Rocha-Singh K, Isner
JM, Kereiakes DJ, Giordano FJ, Simons M and Bonow RO: Effect of
intracoronary recombinant human vascular endothelial growth factor
on myocardial perfusion: Evidence for a dose-dependent effect.
Circulation. 101:118–121. 2000.
|
|
34
|
Eken A, Yetkin MF, Vural A, Okus FZ, Erdem
S, Azizoglu ZB, Haliloglu Y, Cakir M, Turkoglu EM, Kilic O, et al:
Fingolimod alters tissue distribution and cytokine production of
human and murine innate lymphoid cells. Front Immunol.
10:2172019.
|
|
35
|
Li Q, Zhou C, Zhao K, Duan Y, Yue J, Liu
X, Wu J and Deng S: Lymphatic endothelial sphingosine 1-phosphate
receptor 1 enhances macrophage clearance via lymphatic system
following myocardial infarction. Front Cardiovasc Med.
9:8721022022.
|
|
36
|
B Gowda S, Gowda D, Kain V, Chiba H, Hui
SP, Chalfant CE, Parcha V, Arora P and Halade GV:
Sphingosine-1-phosphate interactions in the spleen and heart
reflect extent of cardiac repair in mice and failing human hearts.
Am J Physiol Heart Circ Physiol. 321:H599–H611. 2021.
|
|
37
|
Du M, Shan J, Feng A, Schmull S, Gu J and
Xue S: Oestrogen receptor β activation protects against myocardial
infarction via Notch1 signalling. Cardiovasc Drugs Ther.
34:165–178. 2020.
|
|
38
|
Mahmoodzadeh S, Leber J, Zhang X, Jaisser
F, Messaoudi S, Morano I, Furth PA, Dworatzek E and Regitz-Zagrosek
V: Cardiomyocyte-specific estrogen receptor alpha increases
angiogenesis, lymphangiogenesis and reduces fibrosis in the female
mouse heart post-myocardial infarction. J Cell Sci Ther.
5:1532014.
|
|
39
|
Jeya PJ, Weigel C, Müller T, Heller R,
Spiegel S and Gräler MH: Inflammatory conditions disrupt
constitutive endothelial cell barrier stabilization by alleviating
autonomous secretion of sphingosine 1-phosphate. Cells.
9:9282020.
|
|
40
|
Nagahashi M, Abe M, Sakimura K, Takabe K
and Wakai T: The role of sphingosine-1-phosphate in inflammation
and cancer progression. Cancer Sci. 109:3671–3678. 2018.
|
|
41
|
Tatin F, Renaud-Gabardos E, Godet AC,
Hantelys F, Pujol F, Morfoisse F, Calise D, Viars F, Valet P, Masri
B, et al: Apelin modulates pathological remodeling of lymphatic
endothelium after myocardial infarction. Jci Insight.
2:e938872017.
|
|
42
|
Poh KK, Lee PSS, Djohan AH, Galupo MJ,
Songco GG, Yeo TC, Tan HC, Richards AM and Ye L: Transplantation of
endothelial progenitor cells in obese diabetic rats following
myocardial infarction: Role of thymosin beta-4. Cells.
9:9492020.
|
|
43
|
Wang YL, Yu SN, Shen HR, Wang HJ, Wu XP,
Wang QL, Zhou B and Tan YZ: Thymosin β4 released from
functionalized self-assembling peptide activates epicardium and
enhances repair of infarcted myocardium. Theranostics.
11:4262–4280. 2021.
|
|
44
|
Trincot CE, Xu W, Zhang H, Kulikauskas MR,
Caranasos TG, Jensen BC, Sabine A, Petrova TV and Caron KM:
Adrenomedullin induces cardiac lymphangiogenesis after myocardial
infarction and regulates cardiac edema via connexin 43. Circ Res.
124:101–113. 2019.
|
|
45
|
Lin QY, Zhang YL, Bai J, Liu JQ and Li HH:
VEGF-C/VEGFR-3 axis protects against pressure-overload induced
cardiac dysfunction through regulation of lymphangiogenesis. Clin
Transl Med. 11:e3742021.
|
|
46
|
Glinton KE, Ma W, Lantz C, Grigoryeva LS,
DeBerge M, Liu X, Febbraio M, Kahn M, Oliver G and Thorp EB:
Macrophage-produced VEGFC is induced by efferocytosis to ameliorate
cardiac injury and inflammation. J Clin Invest.
132:e1406852022.
|
|
47
|
McDonagh TA, Metra M, Adamo M, Gardner RS,
Baumbach A, Bohm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et
al: 2021 ESC guidelines for the diagnosis and treatment of acute
and chronic heart failure. Eur Heart J. 42:3599–3726. 2021.
|
|
48
|
Schwinger RHG: Pathophysiology of heart
failure. Cardiovasc Diagn Ther. 11:263–276. 2021.
|
|
49
|
Weckbach LT, Uhl A, Boehm F, Seitelberger
V, Huber BC, Kania G, Brunner S and Grabmaier U: Blocking LFA-1
aggravates cardiac inflammation in experimental autoimmune
myocarditis. Cells. 8:12672019.
|
|
50
|
Tkacz K, Rolski F, Czepiel M, Działo E,
Siedlar M, Eriksson U, Kania G and Błyszczuk P: Haploinsufficient
Rock1+/− and Rock2+/− mice are not protected
from cardiac inflammation and postinflammatory fibrosis in
experimental autoimmune myocarditis. Cells. 9:7002020.
|
|
51
|
Zheng H, Liu X, Katsurada K and Patel KP:
Renal denervation improves sodium excretion in rats with chronic
heart failure: Effects on expression of renal ENaC and AQP2. Am J
Physiol Heart Circ Physiol. 317:H958–H968. 2019.
|
|
52
|
Maier A, Braig M, Jakob K, Bienert T,
Schäper M, Merkle A, Wadle C, Menza M, Neudorfer I, Bojti I, et al:
Molecular magnetic resonance imaging of activated platelets allows
noninvasive detection of early myocarditis in mice. Sci Rep.
10:132112020.
|
|
53
|
Huang B, Miao H, Yuan Y, Qiu F, Liu X, Liu
Z, Zhang H, Zhao Q, Wang M, Dong H and Zhang Z: PEDF decreases
cardiomyocyte edema during oxygen-glucose deprivation and recovery
via inhibiting lactate accumulation and expression of AQP1. Int J
Mol Med. 43:1979–1990. 2019.
|
|
54
|
Card CM, Yu SS and Swartz MA: Emerging
roles of lymphatic endothelium in regulating adaptive immunity. J
Clin Invest. 124:943–952. 2014.
|
|
55
|
Kajiya K and Detmar M: An important role
of lymphatic vessels in the control of uvb-induced edema formation
and inflammation. J Invest Dermatol. 126:919–921. 2006.
|
|
56
|
Li N, Zhu L, Sun L and Shao G: The effects
of novel coronavirus (SARS-CoV-2) infection on cardiovascular
diseases and cardiopulmonary injuries. Stem Cell Res.
51:1021682021.
|
|
57
|
Hata AN and Breyer RM: Pharmacology and
signaling of prostaglandin receptors: Multiple roles in
inflammation and immune modulation. Pharmacol Ther. 103:147–166.
2004.
|
|
58
|
Al-Kofahi M, Omura S, Tsunoda I, Sato F,
Becker F, Gavins FNE, Woolard MD, Pattillo C, Zawieja D, Muthuchamy
M, et al: IL-1β reduces cardiac lymphatic muscle contraction via
COX-2 and PGE2 induction: Potential role in myocarditis. Biomed
Pharmacother. 107:1591–1600. 2018.
|
|
59
|
Forrester SJ, Booz GW, Sigmund CD, Coffman
TM, Kawai T, Rizzo V, Scalia R and Eguchi S: Angiotensin II signal
transduction: An update on mechanisms of physiology and
pathophysiology. Physiol Rev. 98:1627–1738. 2018.
|
|
60
|
Doan TN, Bernard FC, McKinney JM, Dixon JB
and Willett NJ: Endothelin-1 inhibits size dependent lymphatic
clearance of PEG-based conjugates after intra-articular injection
into the rat knee. Acta Biomater. 93:270–281. 2019.
|
|
61
|
Bai J, Yin L, Yu WJ, Zhang YL, Lin QY and
Li HH: Angiotensin II induces cardiac edema and hypertrophic
remodeling through lymphatic-dependent mechanisms. Oxid Med Cell
Longev. 2022:50440462022.
|
|
62
|
Qu X, Song X, Yuan W, Shu Y, Wang Y, Zhao
X, Gao M, Lu R, Luo S, Zhao W, et al: Expression signature of
lncRNAs and their potential roles in cardiac fibrosis of
post-infarct mice. Biosci Rep. 36:e003372016.
|
|
63
|
Iwamiya T, Segard BD, Matsuoka Y and
Imamura T: Human cardiac fibroblasts expressing VCAM1 improve heart
function in postinfarct heart failure rat models by stimulating
lymphangiogenesis. PLoS One. 15:e02378102020.
|
|
64
|
Simko F, Pechanova O, Repova K, Aziriova
S, Krajcirovicova K, Celec P, Tothova L, Vrankova S, Balazova L,
Zorad S and Adamcova M: Lactacystin-induced model of hypertension
in rats: Effects of melatonin and captopril. Int J Mol Sci.
18:16122017.
|
|
65
|
Pan L, Sun X, Che H and Li M: CTRP9
mitigates vascular endothelial cell injury in patients with
hypertensive heart disease by inhibiting PI3K/Akt/mTOR axis. Am J
Transl Res. 14:6596–6603. 2022.
|
|
66
|
Sterns RH: Disorders of plasma
sodium-causes, consequences, and correction. N Engl J Med.
372:55–65. 2015.
|
|
67
|
Balasubbramanian D, Baranwal G, Clark MCC,
Goodlett BL, Mitchell BM and Rutkowski JM: Kidney-specific
lymphangiogenesis increases sodium excretion and lowers blood
pressure in mice. J Hypertens. 38:874–885. 2020.
|
|
68
|
Wiig H, Schröder A, Neuhofer W, Jantsch J,
Kopp C, Karlsen TV, Boschmann M, Goss J, Bry M, Rakova N, et al:
Immune cells control skin lymphatic electrolyte homeostasis and
blood pressure. J Clin Invest. 123:2803–2815. 2013.
|
|
69
|
Machnik A, Dahlmann A, Kopp C, Goss J,
Wagner H, van Rooijen N, Eckardt KU, Müller DN, Park JK, Luft FC,
et al: Mononuclear phagocyte system depletion blocks interstitial
tonicity-responsive enhancer binding protein/vascular endothelial
growth factor C expression and induces salt-sensitive hypertension
in rats. Hypertension. 55:755–761. 2010.
|
|
70
|
Yang GH, Zhou X, Ji WJ, Zeng S, Dong Y,
Tian L, Bi Y, Guo ZZ, Gao F, Chen H, et al: Overexpression of
VEGF-C attenuates chronic high salt intake-induced left ventricular
maladaptive remodeling in spontaneously hypertensive rats. Am J
Physiol Heart Circ Physiol. 306:H598–H609. 2014.
|
|
71
|
Ye BJ, Lee HH, Yoo EJ, Lee CY, Lee JH,
Kang HJ, Jeong GW, Park H, Lee-Kwon W, Choi SY and Kwon HM: TonEBP
in dendritic cells mediates pro-inflammatory maturation and
Th1/Th17 responses. Cell Death Dis. 11:4212020.
|
|
72
|
Yang GH, Zhou X, Ji WJ, Liu JX, Sun J,
Dong Y, Jiang TM and Li YM: VEGF-C-mediated cardiac
lymphangiogenesis in high salt intake accelerated progression of
left ventricular remodeling in spontaneously hypertensive rats.
Clin Exp Hypertens. 39:740–747. 2017.
|
|
73
|
Zhang C, Li N, Suo M, Zhang C, Liu J, Liu
L, Qi Y, Zheng X, Xie L, Hu Y and Bu P: Sirtuin 3 deficiency
aggravates angiotensin II-induced hypertensive cardiac injury by
the impairment of lymphangiogenesis. J Cell Mol Med. 25:7760–7771.
2021.
|
|
74
|
Hosios AM and Vander Heiden MG:
Endothelial cells Get β-ox-ed in to support lymphangiogenesis. Dev
Cell. 40:118–119. 2017.
|
|
75
|
Li X, Qiu J, Pan M, Zheng D, Su Y, Wei M,
Kong X, Sun W and Zhu J: Correlation between congenital heart
disease complicated with pulmonary artery hypertension and
circulating endothelial cells as well as endothelin-1. Int J Clin
Exp Pathol. 8:10743–10751. 2015.
|
|
76
|
Kelly B, Mohanakumar S and Hjortdal VE:
Diagnosis and management of lymphatic disorders in congenital heart
disease. Curr Cardiol Rep. 22:1642020.
|
|
77
|
Li D, Sheppard SE, March ME, Battig MR,
Surrey LF, Srinivasan AS, Matsuoka LS, Tian L, Wang F, Seiler C, et
al: Genomic profiling informs diagnoses and treatment in vascular
anomalies. Nat Med. 29:1530–1539. 2023.
|
|
78
|
Boehme JT, Morris CJ, Chiacchia SR, Gong
W, Wu KY, Kameny RJ, Raff GW, Fineman JR, Maltepe E and Datar SA:
HIF-1α promotes cellular growth in lymphatic endothelial cells
exposed to chronically elevated pulmonary lymph flow. Sci Rep.
11:14682021.
|
|
79
|
Scallan JP, Hill MA and Davis MJ:
Lymphatic vascular integrity is disrupted in type 2 diabetes due to
impaired nitric oxide signalling. Cardiovasc Res. 107:89–97.
2015.
|
|
80
|
Hwang J, Kleinhenz DJ, Lassegue B,
Griendling KK, Dikalov S and Hart CM: Peroxisome
proliferator-activated receptor-gamma ligands regulate endothelial
membrane superoxide production. Am J Physiol Cell Physiol.
288:C899–C905. 2005.
|
|
81
|
Choi D, Park E, Jung E, Seong YJ, Hong M,
Lee S, Burford J, Gyarmati G, Peti-Peterdi J, Srikanth S, et al:
ORAI1 activates proliferation of lymphatic endothelial cells in
response to laminar flow through Krüppel-like factors 2 and 4. Circ
Res. 120:1426–1439. 2017.
|
|
82
|
Morris CJ, Kameny RJ, Boehme J, Gong W, He
Y, Zhu T, Maltepe E, Raff GW, Fineman JR and Datar SA:
KLF2-mediated disruption of PPAR-γ signaling in lymphatic
endothelial cells exposed to chronically increased pulmonary lymph
flow. Am J Physiol Heart Circ Physiol. 315:H173–H181. 2018.
|
|
83
|
Yu J, Mao L, Guan L, Zhang Y and Zhao J:
Ginsenoside Rg1 enhances lymphatic transport of intrapulmonary
silica via VEGF-C/VEGFR-3 signaling in silicotic rats. Biochem
Biophys Res Commun. 472:182–188. 2016.
|
|
84
|
Allard B, Cousineau I, Allard D, Buisseret
L, Pommey S, Chrobak P and Stagg J: Adenosine A2a receptor promotes
lymphangiogenesis and lymph node metastasis. Oncoimmunology.
8:16014812019.
|
|
85
|
Han H, Ma Y, Wang X, Yun R, Lu S, Xia M,
Wang Y, Shi Q, Zhai W, Liang Q and Xu H: Fang-Ji-Huang-Qi-Tang
attenuates degeneration of early-stage KOA mice related to
promoting joint lymphatic drainage function. Evid Based Complement
Alternat Med. 2020:34716812020.
|
|
86
|
Chen Y, Li J, Li Q, Wang T, Xing L, Xu H,
Wang Y, Shi Q, Zhou Q and Liang Q: Du-Huo-Ji-Sheng-Tang attenuates
inflammation of TNF-Tg mice related to promoting lymphatic drainage
function. Evid Based Complement Alternat Med. 2016:70676912016.
|
|
87
|
Hou T, Liu Y, Wang X, Jiao D, Xu H, Shi Q,
Wang Y, Li W, Wu T and Liang Q: Ginsenoside Rg1 promotes lymphatic
drainage and improves chronic inflammatory arthritis. J
Musculoskelet Neuronal Interact. 20:526–534. 2020.
|
|
88
|
Ishii M, Miyata H, Ikeda N, Tagawa T and
Nishimura M: Piper retrofractum extract and its component piperine
promote lymphangiogenesis via an AKT- and ERK-dependent mechanism.
J Food Biochem. 46:e142332022.
|
|
89
|
Li J, Chen Y, Zhang L, Xing L, Xu H, Wang
Y, Shi Q and Liang Q: Total saponins of panaxnotoginseng promotes
lymphangiogenesis by activation vegf-c expression of lymphatic
endothelial cells. J Ethnopharmacol. 193:293–302. 2016.
|
|
90
|
Peng L, Dong Y, Fan H, Cao M, Wu Q and
Wang Y, Zhou C, Li S, Zhao C and Wang Y: Traditional Chinese
medicine regulating lymphangiogenesis: A literature review. Front
Pharmacol. 11:12592020.
|
|
91
|
Benvenuti LA, da Silva AMG and Aiello VD:
Quantification of lymphatic vessels in dilated and chronic chagasic
cardiomyopathy. Arq Bras Cardiol. 94:564–567. 2010.In
Portuguese.
|
|
92
|
Peng L, Ma M, Dong Y, Wu Q, An S, Cao M,
Wang Y, Zhou C, Zhou M, Wang X, et al: Kuoxin Decoction promotes
lymphangiogenesis in zebrafish and in vitro based on network
analysis. Front Pharmacol. 13:9151612022.
|
|
93
|
Shi J, Liang Q, Zuscik M, Shen J, Chen D,
Xu H, Wang YJ, Chen Y, Wood RW, Li J, et al: Distribution and
alteration of lymphatic vessels in knee joints of normal and
osteoarthritic mice. Arthritis Rheumatol. 66:657–666. 2014.
|
|
94
|
Lou B, Wu W, Zeng L, Zhou W, Zhang X, Zhou
X, Liu Z, Liu K, Gu X, Chen X, et al: Alleviating experimental
allergic eye disease by inhibiting pro-lymphangiogenic VEGFR3
signal. Ocul Surf. 26:1–12. 2022.
|
|
95
|
Ahn JH, Cho H, Kim JH, Kim SH, Ham JS,
Park I, Suh SH, Hong SP, Song JH, Hong YK, et al: Meningeal
lymphatic vessels at the skull base drain cerebrospinal fluid.
Nature. 572:62–66. 2019.
|
|
96
|
Da Mesquita S, Papadopoulos Z, Dykstra T,
Brase L, Farias FG, Wall M, Jiang H, Kodira CD, de Lima KA, Herz J,
et al: Meningeal lymphatics affect microglia responses and anti-Aβ
immunotherapy. Nature. 593:255–260. 2021.
|
|
97
|
Nedergaard M and Goldman SA: Glymphatic
failure as a final common pathway to dementia. Science. 370:50–56.
2020.
|
|
98
|
Li X, Qi L, Yang D, Hao S, Zhang F, Zhu X,
Sun Y, Chen C, Ye J, Yang J, et al: Meningeal lymphatic vessels
mediate neurotropic viral drainage from the central nervous system.
Nat Neurosci. 25:577–587. 2022.
|
|
99
|
Zhou M and Wang Y, Zhou C, Peng L, Liang Q
and Wang Y: A research progress of Traditional Chinese medicine
acting on the lymphangiogenesis and lymphatic drainage function.
Mod Tradit Chin Med Materia Medica-World Sci Tech. 24:802–809.
2022.In Chinese.
|
|
100
|
Qi SM, Zhang JT, Zhu HY, Wang Z and Li W:
Review on potential effects of traditional Chinese medicine on
glaucoma. J Ethnopharmacol. 304:1160632023.
|
|
101
|
Zhang J, Li Q and Zhou YY: Research
progress on mechanism of traditional Chinese medicine
polysaccharides in preventing and treating Alzheimer's disease.
Chin Tradit Herb Drugs. 53:7553–7565. 2022.In Chinese.
|
|
102
|
Zhang QM, Wang YG, Zhang JX, Han XY and
Tian X: Functional properties and biological basis of essence, qi,
blood and body fluid. Glob Tradit Chin Med. 14:841–847. 2021.
|
|
103
|
Cui JK, Chen X and Jiang Q: Discussion on
the treatment of Sjogren's syndrome from the metabolism of body
fluid. J Basic Chin Med. 25:1662–1663. 2019.In Chinese.
|
|
104
|
Jiang L, Zhao JX, Zhang YF, Meng FZ, Jian
J and Liu JT: Discussion on the treatment of diabetic kidney
disease edema in traditional Chinese medicine based on the theory
of qi, blood and water. China J Tradit Chin Med Pharm. 36:887–890.
2021.In Chinese.
|
|
105
|
Fang Y, Huang K and Li X: Preliminary
study on the blood circulation characteristics of phlegm syndrome.
Hubei J Tradit Chin Med. 1:33–34. 1992.In Chinese.
|
|
106
|
Wei D, Liu M and Shi X: A study on the
distribution of traditional Chinese medicine syndromes of elevated
blood glucose in the acute stage of stroke. J Emerg Tradit Chin
Med. 10:91–92. 2001.In Chinese.
|
|
107
|
Wang J, Yan C, Deng Z and Pan Y: Exploring
the mechanism of phlegm syndrome from the abnormal metabolism of
adhesion molecules. Chin J Integr Tradit West Med. 20:296–297.
2000.In Chinese.
|
|
108
|
Yu S, Liu C, Zhou L, Zhong Y, Xiong N, Xu
J, Liu C, Cheng S and Wang P: Wendantang treats inflammation in
obesity (Syndrome of Phlegm-dampness) by regulatingPI3K/Akt/mTOR
pathway-mediated adipocyte autophagy. Chin J Exp Tradit Med
Formulae. 29:1–10. 2023.In Chinese.
|
|
109
|
Yi GH: Lymphatic vessels: A potential path
to intervene the development of atherosclerosis. Chin J
Arterioscler. 26:973–979. 2018.In Chinese.
|
|
110
|
Mikami T, Koyama A, Hashimoto K, Maegawa
J, Yabuki Y, Kagimoto S, Kitayama S, Kaneta T, Yasumura K,
Matsubara S and Iwai T: Pathological changes in the lymphatic
system of patients with secondary upper limb lymphoedema. Sci Rep.
9:84992019.
|
|
111
|
Mukherjee A, Hooks J, Nepiyushchikh Z and
Dixon JB: Entrainment of lymphatic contraction to oscillatory flow.
Sci Rep. 9:58402019.
|
|
112
|
Huang SW, Yang HY, Huang WJ, Chen WC, Yu
MC, Wang SW, Hsu YF and Hsu MJ: WMJ-S-001, a novel aliphatic
hydroxamate-based compound, suppresses lymphangiogenesis through
p38mapk-p53-survivin signaling cascade. Front Oncol.
9:11882019.
|
|
113
|
Shinriki S, Jono H, Ueda M, Ota K, Ota T,
Sueyoshi T, Oike Y, Ibusuki M, Hiraki A, Nakayama H, et al:
Interleukin-6 signalling regulates vascular endothelial growth
factor-C synthesis and lymphangiogenesis in human oral squamous
cell carcinoma. J Pathol. 225:142–150. 2011.
|
|
114
|
Zhang N, Hu H, Fu Y, He F, Wang L, Zhuang
S and Ding M: The overexpression of PDGF-BB and its receptor is
correlated with lymphatic metastasis in patients with non-small
cell lung cancer. Int J Clin Exp Pathol. 11:6010–6017. 2018.
|
|
115
|
Caunt M, Mak J, Liang WC, Stawicki S, Pan
Q, Tong RK, Kowalski J, Ho C, Reslan HB, Ross J, et al: Blocking
neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell.
13:331–342. 2008.
|
|
116
|
Song J, Chen W, Cui X, Huang Z, Wen D,
Yang Y, Yu W, Cui L and Liu CY: CCBE1 promotes tumor
lymphangiogenesis and is negatively regulated by TGFβ signaling in
colorectal cancer. Theranostics. 10:2327–2341. 2020.
|
|
117
|
Haemmerle M, Keller T, Egger G, Schachner
H, Steiner CW, Stokic D, Neumayer C, Brown MK, Kerjaschki D and
Hantusch B: Enhanced lymph vessel density, remodeling, and
inflammation are reflected by gene expression signatures in dermal
lymphatic endothelial cells in type 2 diabetes. Diabetes.
62:2509–2529. 2013.
|
|
118
|
Morooka N, Futaki S, Sato-Nishiuchi R,
Nishino M, Totani Y, Shimono C, Nakano I, Nakajima H, Mochizuki N
and Sekiguchi K: Polydom is an extracellular matrix protein
involved in lymphatic vessel remodeling. Circ Res. 120:1276–1288.
2017.
|
|
119
|
Choi D, Park E, Yu RP, Cooper MN, Cho IT,
Choi J, Yu J, Zhao L, Yum JI, Yu JS, et al: Piezo1-regulated
mechanotransduction controls flow-activated lymphatic expansion.
Circ Res. 131:e2–e21. 2022.
|
|
120
|
Klotz L, Norman S, Vieira JM, Masters M,
Rohling M, Dubé KN, Bollini S, Matsuzaki F, Carr CA and Riley PR:
Cardiac lymphatics are heterogeneous in origin and respond to
injury. Nature. 522:62–67. 2015.
|
|
121
|
Lim HY, Thiam CH, Yeo KP, Bisoendial R,
Hii CS, McGrath KC, Tan KW, Heather A, Alexander JS and Angeli V:
Lymphatic vessels are essential for the removal of cholesterol from
peripheral tissues by SR-BI-mediated transport of HDL. Cell Metab.
17:671–684. 2013.
|
|
122
|
Dashkevich A, Raissadati A, Syrjälä SO,
Zarkada G, Keränen MA, Tuuminen R, Krebs R, Anisimov A, Jeltsch M,
Leppanen VM, et al: Ischemia-reperfusion injury enhances lymphatic
endothelial VEGFR3 and rejection in cardiac allografts. Am J
Transplant. 16:1160–1172. 2016.
|
|
123
|
Losordo DW, Vale PR, Hendel RC, Milliken
CE, Fortuin FD, Cummings N, Schatz RA, Asahara T, Isner JM and
Kuntz RE: Phase 1/2 placebo-controlled, double-blind,
dose-escalating trial of myocardial vascular endothelial growth
factor 2 gene transfer by catheter delivery in patients with
chronic myocardial ischemia. Circulation. 105:2012–2018. 2002.
|
|
124
|
Hartikainen J, Hassinen I, Hedman A,
Kivelä A, Saraste A, Knuuti J, Husso M, Mussalo H, Hedman M,
Rissanen TT, et al: Adenoviral intramyocardial VEGF-DΔNΔC gene
transfer increases myocardial perfusion reserve in refractory
angina patients: A phase I/IIa study with 1-year follow-up. Eur
Heart J. 38:2547–2555. 2017.
|
|
125
|
O'Dwyer J, Murphy R, Dolan EB, Kovarova L,
Pravda M, Velebny V, Heise A, Duffy GP and Cryan SA: Development of
a nanomedicine-loaded hydrogel for sustained delivery of an
angiogenic growth factor to the ischaemic myocardium. Drug Deliv
Transl Res. 10:440–454. 2020.
|
|
126
|
O'Dwyer J, Murphy R, González-Vázquez A,
Kovarova L, Pravda M, Velebny V, Heise A, Duffy GP and Cryan SA:
Translational studies on the potential of a VEGF
nanoparticle-loaded hyaluronic acid hydrogel. Pharmaceutics.
13:7792021.
|
|
127
|
Zheng W, Aspelund A and Alitalo K:
Lymphangiogenic factors, mechanisms, and applications. J Clin
Invest. 124:878–887. 2014.
|
|
128
|
Hu D, Li L, Li S, Wu M, Ge N, Cui Y, Lian
Z, Song J and Chen H: Lymphatic system identification,
pathophysiology and therapy in the cardiovascular diseases. J Mol
Cell Cardiol. 133:99–111. 2019.
|
|
129
|
Hwang SD, Song JH, Kim Y, Lim JH, Kim MY,
Kim EN, Hong YA, Chung S, Choi BS, Kim YS and Park CW: Inhibition
of lymphatic proliferation by the selective VEGFR-3 inhibitor
SAR131675 ameliorates diabetic nephropathy in db/db mice. Cell
Death Dis. 10:2192019.
|
|
130
|
Rahbar E, Weimer J, Gibbs H, Yeh AT,
Bertram CD, Davis MJ, Hill MA, Zawieja DC and Moore JE Jr: Passive
pressure-diameter relationship and structural composition of rat
mesenteric lymphangions. Lymphat Res Biol. 10:152–163. 2012.
|
|
131
|
Fang Y, Wang XY, You JF, Liang QQ and
Zheng WC: Jia-Wei-Niu-Bang-Zi-Tang promotes lymphangiogenesis in
TNF-α transgenic mice and alleviates rheumatoid arthritis. Chin
Pharmacol Bulletin. 37:1469–1474. 2021.In Chinese.
|
|
132
|
Feng X, Sun H, Gao F and Ma W: Observation
of curative effect of the treatment of lymphedema of upper limb
after breast cancer operation with fumigation and washing of
traditional Chinese medicine combined with acupoint application of
Jiawei Jinhuang ointment. J Mod Oncol. 31:1252–1256. 2023.In
Chinese.
|
|
133
|
Lohrke J, Frenzel T, Endrikat J, Alves FC,
Grist TM, Law M, Lee JM, Leiner T, Li KC, Nikolaou K, et al: 25
years of contrast-enhanced MRI: Developments, current challenges
and future perspectives. Adv Ther. 33:1–28. 2016.
|
|
134
|
Quintanilla M, Montero-Montero L, Renart J
and Martin-Villar E: Podoplanin in inflammation and cancer. Int J
Mol Sci. 20:7072019.
|
|
135
|
Aldea R, Weller RO, Wilcock DM, Carare RO
and Richardson G: Cerebrovascular smooth muscle cells as the
drivers of intramural periarterial drainage of the brain. Front
Aging Neurosci. 11:12019.
|
|
136
|
Brakenhielm E and Alitalo K: Cardiac
lymphatics in health and disease. Nat Rev Cardiol. 16:56–68.
2019.
|
|
137
|
Gordon-Walker TT, Bove K and Veldtman G:
Fontan-associated liver disease: A review. J Cardiol. 74:223–232.
2019.
|
|
138
|
Savla JJ, Itkin M, Rossano JW and Dori Y:
Post-operative chylothorax in patients with congenital heart
disease. J Am Coll Cardiol. 69:2410–2422. 2017.
|
|
139
|
Goumans MJ, Zwijsen A, Ten Dijke P and
Bailly S: Bone morphogenetic proteins in vascular homeostasis and
disease. Cold Spring Harb Perspect Biol. 10:a0319892018.
|
|
140
|
Nash LA, Burns JK, Chardon JW, Kothary R
and Parks RJ: Spinal muscular atrophy: More than a disease of motor
neurons? Curr Mol Med. 16:779–792. 2016.
|
|
141
|
Melenotte C, Protopopescu C, Million M,
Edouard S, Carrieri MP, Eldin C, Angelakis E, Djossou F, Bardin N,
Fournier PE, et al: Clinical features and complications of coxiella
burnetii infections from the french national reference center for Q
fever. JAMA Netw Open. 1:e1815802018.
|
|
142
|
Vieira JM, Norman S, Villa Del Campo C,
Cahill TJ, Barnette DN, Gunadasa-Rohling M, Johnson LA, Greaves DR,
Carr CA, Jackson DG and Riley PR: The cardiac lymphatic system
stimulates resolution of inflammation following myocardial
infarction. J Clin Invest. 128:3402–3412. 2018.
|
|
143
|
Chavhan GB, Amaral JG, Temple M and Itkin
M: MR lymphangiography in children: Technique and potential
applications. Radiographics. 37:1775–1790. 2017.
|
